Prosecution Insights
Last updated: April 19, 2026

Lankenau Institute For Medical Research

6 pending office actions

Portfolio Summary

6
Total Pending OAs
1
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18443701 METHODS AND COMPOSITIONS FOR INDUCIBLE EXTRACELLULAR MEMBRANE CAPTURE OF MONOCLONAL IMMUNOGLOBULINS SECRETED BY HYBRIDOMAS ROONEY, NORA MAUREEN 1641 Non-Final OA Feb 16, 2024
18491078 Nucleic Acid Molecules Encoding Indoleamine 2,3-Dioxygenase-2 ORWIG, KEVIN S 3991 Non-Final OA Oct 20, 2023
18446153 METHODS AND COMPOSITIONS FOR ASSESSING AND TREATING EMETOGENIC DRUG-RELATED NAUSEA SAEED, ALI S 1616 Non-Final OA Aug 08, 2023
18357452 METHODS AND COMPOSITIONS COMPRISING FUSION PROTEINS FOR THE IDENTIFICATION OF IMMUNOTHERAPY CELLS REDDIG, PETER J 1646 Non-Final OA Jul 24, 2023
18158327 METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETINOPATHY AND OTHER OCULAR DISEASES SOLOLA, TAOFIQ A 1625 Final Rejection Jan 23, 2023
18004618 COMPOSITIONS COMPRISING ANTIBODIES TO HUMAN IDO-2 STONEBRAKER, ALYSSA RAE 1642 Non-Final OA Jan 06, 2023

Managing Lankenau Institute For Medical Research's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month